See also this year's filing and all EDGAR filings for this company.
PDF Report 0001672619_2021_Enliven_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001672619')"} |
Graph
Absolute values for 0001672619, Enliven Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 90,405,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 349,000 |
| 3 | remainder_Assets | 88,000 |
| 4 | LiabilitiesCurrent | 6,247,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 160,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,544,000 |
| 9 | ResearchAndDevelopmentExpense | 32,154,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 338,000 |
| 13 | remainder_ComprehensiveNetIncome | -28,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 90,842,000 |
| 1 | Liabilities | 6,407,000 |
| 2 | Expenses | 41,698,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 84,435,000 |
| 5 | NetIncome | -41,360,000 |
| 6 | ComprehensiveNetIncome | -41,374,000 |
| 7 | BaseVar | 69,656,500 |
| 8 | EconomicCapitalRatio | 2.14 |
Edgar->Model Mapping
Feature Distribution
Change over Time
